جست‌وجوی استاد و پژوهشگر

• Membrane Protein Biochemistry
• Pharmacology
• Drug Design
• +۵ مورد دیگر

Jonas Sigurd Mortensen serves as an Assistant Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen, specifically within the Molecular and Cellular Pharmacology division. His research program bridges fundamental biochemistry with pharmacological applications, focusing on two interconnected domains: the development of novel detergents for membrane protein stabilization and investigations into neurotransmitter systems, particularly GABA transporters and kinase signaling pathways. Dr. Mortensen's research interests center around membrane protein biochemistry and neuropharmacology. His work in detergent development addresses a critical technical challenge in structural biology—maintaining the stability and functionality of membrane proteins outside their native lipid environment. He has systematically investigated how structural variations in detergents (including rigidity-flexibility balance, core flexibility, and pendant chain characteristics) affect protein stability. This foundational work enables more effective structural and functional studies of membrane proteins, which represent important drug targets. Concurrently, his pharmacological research explores GABA transporter modulation as a therapeutic strategy for neurological disorders and examines allosteric factors in kinase regulation related to GHB pharmacology, demonstrating the translational potential of his biochemical expertise. Analysis of Dr. Mortensen's publication record reveals a strong trajectory in membrane protein biochemistry, with numerous papers describing innovative amphiphile designs including various maltosides, tetraglucosides, and other specialized detergents. His recent work has expanded into neuropharmacology, with publications examining GABA transporter modulation for neurological disease treatment and investigating calcium/calmodulin-responsive kinase II domains. This evolution demonstrates how his technical expertise in membrane protein stabilization directly supports investigations of pharmacologically relevant targets. Dr. Mortensen maintains extensive collaborations with researchers across multiple institutions, as evidenced by his co-authorship on numerous publications with scientists including Claus J. Loland, Paul R. Eriksson, and various international collaborators. His research output includes 35 publications comprising 33 journal articles, 1 book chapter, and 1 review article, with significant citations and engagement on academic platforms like Mendeley and social media. His laboratory likely employs a comprehensive suite of biochemical, biophysical, and pharmacological techniques to investigate membrane protein structure-function relationships and develop novel pharmacological tools. While specific grant information isn't detailed in the available text, his productive publication record across high-impact journals suggests successful funding of his research program. Dr. Mortensen's work has practical implications for drug discovery, particularly in neurological disorders where membrane proteins serve as important therapeutic targets, positioning his research at the critical intersection of basic science and therapeutic development.

• Pharmacology
• Neuropharmacology
• Ion Channel Research
• +۴ مورد دیگر

Uffe Kristiansen is an Associate Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on ionotropic receptors for inhibitory amino acids, particularly GABA and glycine receptors, with emphasis on their relation to epilepsy. Dr. Kristiansen's primary research areas include: Pharmacodynamics of fast, desensitizing receptors Kinetics of ligand-receptor interaction at $$\text{GABA}_{\text{A}}$$ receptors Inhibitory neurotransmission mechanisms Receptor selectivity through kinetic principles His laboratory employs a combination of patch-clamp electrophysiology with variable rates of ligand application, different methods of response measurements, and kinetic computer modeling to optimize experimental design and quantification methods. This approach increases information yield and validity of conclusions in pharmacological studies. A notable concept developed by his team is 'receptor selectivity by kinetics,' which leverages the inherent differences in time-concentration profiles of neurotransmitters at synaptic versus extrasynaptic receptors to improve drug selectivity. Dr. Kristiansen's research publications span pharmacology, neuroscience, and computational modeling, with recent work focusing on $$\text{GABA}_{\text{A}}$$ receptor antagonists, ion channel kinetics, and novel approaches to studying inhibitory neurotransmission. His work has implications for developing more selective treatments for neurological disorders, particularly epilepsy. His scientific contributions include: Development of kinetic models for receptor interactions Studies on receptor selectivity mechanisms Investigations of $$\text{GABA}_{\text{A}}$$ receptor pharmacology Research on ion channel function in neurological disorders Dr. Kristiansen teaches courses in general physiology, neurophysiology and pharmacology, pharmacodynamics, and ion channel kinetics, contributing to the education of future pharmacologists and neuroscientists.

• Neuroscience
• Sleep Medicine
• Narcolepsy Research
• +۵ مورد دیگر

Louise Saviø Piilgaard is a Guest Researcher in the Neuronal Signalling research group within the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research is conducted at the Blegdamsvej 3 campus in Copenhagen. Dr. Piilgaard's research focuses on the intersection of sleep medicine, electrophysiology, and neurological disorders, with particular expertise in narcolepsy research. Her work heavily utilizes mouse models to investigate sleep-wake dynamics, EEG patterns, and neurological mechanisms underlying sleep disorders. She has made significant contributions to understanding narcolepsy type 1 through innovative approaches to EEG and EMG data analysis, as well as developing non-invasive monitoring techniques for disease progression. Analysis of her publication record from 2019-2025 reveals a strong focus on narcolepsy research, particularly using mouse models to investigate disease mechanisms. Her work spans multiple approaches including electrophysiological analysis, behavioral monitoring, and pharmacological investigations. A notable trend is her progression from basic receptor pharmacology studies toward more complex disease modeling and machine learning applications for disease prediction. Dr. Piilgaard has established productive collaborations with researchers across multiple institutions, as evidenced by her co-authorship on publications with diverse research teams. Her work has received attention across academic platforms, with multiple publications highlighted on social media and research-sharing sites.